Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Leclercq

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Clinical Science (London, England : 1979)|November 26, 2024
New discoveries in bile acids, gut microbiota and host interactions in health and diseasesJustine Gillard, Isabelle Leclercq
Clinical Science (London, England : 1979)|October 13, 2016
Colonic acetate in obesity: location matters!Laure B Bindels, Isabelle Leclercq
Journal of Clinical and Translational Hepatology|September 11, 2015
Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under DevelopmentBénédicte Delire, Peter Stärkel, Isabelle Leclercq
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 24, 2007
Role of signal transducer and activator of transcription 3 in liver fibrosis progression in chronic hepatitis C-infected patientsPeter Stärkel, Christine De Saeger, Isabelle Leclercq, et al.
Interactive Journal of Medical Research|February 17, 2026
Evidence-Based Self-Management Strategies for Fibromyalgia: Foundations for Digital Therapeutic ApplicationsThomas Lebeau Foustoukos, Isabelle Leclercq, Marc Blanchard, et al.
Hepatology (Baltimore, Md.)|December 25, 2002
Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioningNarci Teoh, Isabelle Leclercq, Aileen Dela Pena, et al.
Alcohol, Clinical & Experimental Research|April 15, 2023
Serum keratin 18-M65 levels detect progressive forms of alcohol-associated liver disease in early noncirrhotic stagesLuca Maccioni, Yves Horsmans, Isabelle Leclercq, et al.
Hepatology (Baltimore, Md.)|May 4, 2004
Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in miceEmilia Ip, Geoff Farrell, Pauline Hall, et al.
Journal of Hepatology|August 16, 2005
Deficient Stat3 DNA-binding is associated with high Pias3 expression and a positive anti-apoptotic balance in human end-stage alcoholic and hepatitis C cirrhosisPeter Stärkel, Christine De Saeger, Isabelle Leclercq, et al.
Magnetic Resonance in Medicine|October 9, 2019
Insights into tissue microstructure using a double diffusion encoding sequence on a clinical scanner: Validation and application to experimental tumor modelsGaëtan Duchêne, Jorge Abarca-Quinones, Isabelle Leclercq, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Clinical Science (London, England : 1979)|November 26, 2024
New discoveries in bile acids, gut microbiota and host interactions in health and diseasesJustine Gillard, Isabelle Leclercq
Clinical Science (London, England : 1979)|October 13, 2016
Colonic acetate in obesity: location matters!Laure B Bindels, Isabelle Leclercq
Journal of Clinical and Translational Hepatology|September 11, 2015
Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under DevelopmentBénédicte Delire, Peter Stärkel, Isabelle Leclercq
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 24, 2007
Role of signal transducer and activator of transcription 3 in liver fibrosis progression in chronic hepatitis C-infected patientsPeter Stärkel, Christine De Saeger, Isabelle Leclercq, et al.
Interactive Journal of Medical Research|February 17, 2026
Evidence-Based Self-Management Strategies for Fibromyalgia: Foundations for Digital Therapeutic ApplicationsThomas Lebeau Foustoukos, Isabelle Leclercq, Marc Blanchard, et al.
Hepatology (Baltimore, Md.)|December 25, 2002
Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioningNarci Teoh, Isabelle Leclercq, Aileen Dela Pena, et al.
Alcohol, Clinical & Experimental Research|April 15, 2023
Serum keratin 18-M65 levels detect progressive forms of alcohol-associated liver disease in early noncirrhotic stagesLuca Maccioni, Yves Horsmans, Isabelle Leclercq, et al.
Hepatology (Baltimore, Md.)|May 4, 2004
Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in miceEmilia Ip, Geoff Farrell, Pauline Hall, et al.
Journal of Hepatology|August 16, 2005
Deficient Stat3 DNA-binding is associated with high Pias3 expression and a positive anti-apoptotic balance in human end-stage alcoholic and hepatitis C cirrhosisPeter Stärkel, Christine De Saeger, Isabelle Leclercq, et al.
Magnetic Resonance in Medicine|October 9, 2019
Insights into tissue microstructure using a double diffusion encoding sequence on a clinical scanner: Validation and application to experimental tumor modelsGaëtan Duchêne, Jorge Abarca-Quinones, Isabelle Leclercq, et al.
Pageof 6